The Diagnosis of Beta-lactam Hypersensitivity in Thailand
The Optimized Diagnostic Methods for the Confirmation of Beta-lactam Hypersensitivity in Thailand
1 other identifier
observational
500
1 country
1
Brief Summary
The true prevalence of drug allergy in patients with a history of beta-lactam hypersensitivity will be determined by using commercially available standard skin test reagents and the diagnostic agents available in Thailand. We hypothesize that only minority of patients with such a history are truly allergic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 15, 2012
CompletedFirst Posted
Study publicly available on registry
August 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedOctober 29, 2019
October 1, 2019
6.5 years
August 15, 2012
October 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The true prevalence of drug allergy in patients with a history of beta-lactam hypersensitivity
The skin test positive rate in patients with a history of beta-lactam hypersensitivity
1 year
Secondary Outcomes (1)
Clinical values of various diagnostic modalities in patients with a history of beta-lactam hypersensitivity
1 year
Study Arms (1)
Patients with suspected drug allergy
Patients with a history of hypersensitivity reaction to beta-lactam antibiotics
Eligibility Criteria
Patients with a history of beta-lactam hypersensitivity
You may qualify if:
- Patients with a history of beta-lactam hypersensitivity
You may not qualify if:
- Being pregnant
- Having serious medical illnesses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chulalongkorn University
Bangkok, 10330, Thailand
Related Publications (1)
Chongpison Y, Palapinyo S, Mongkolpathumrat P, Buranapraditkun S, Thantiworasit P, Klaewsongkram J. Beta-lactam hypersensitivity diagnosis in ambulatory and hospitalized settings require different approaches. Ann Allergy Asthma Immunol. 2023 Jan;130(1):84-92.e1. doi: 10.1016/j.anai.2022.09.011. Epub 2022 Sep 16.
PMID: 36122888DERIVED
Biospecimen
Peripheral blood mononuclear cells in patients with a history of non-immediate reaction
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jettanong Klaewsongkram, MD
Chulalongkorn University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 15, 2012
First Posted
August 17, 2012
Study Start
June 1, 2012
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
October 29, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share